Latest updates for Bayer U.s.

Fresh curated links around Bayer U.S. are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bayer to invest $2.2 billion in Ohio pharmaceutical manufacturing site
  • Bayer Picks New Albany, Ohio, for $2.2 Billion Drug Manufacturing Site
  • Bayer Sets $2.2B Ohio Pharma Campus for 2027 Start

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

roi-nj.com /2 weeks ago

Bayer to invest $2.2 billion in Ohio pharmaceutical manufacturing site

Bayer, whose U.S. pharmaceutical headquarters is in Whippany, plans to invest $2.2 billion in a new manufacturing site in New Albany, Ohio, to support production of medicines for i...

Read source
supplychain247.com /2 weeks ago

Bayer Picks New Albany, Ohio, for $2.2 Billion Drug Manufacturing Site

Bayer plans to invest $2.2 billion in a pharmaceutical factory in New Albany, Ohio, that will create about 600 jobs and open in 2031.

Read source
enr.com /2 weeks ago

Bayer Sets $2.2B Ohio Pharma Campus for 2027 Start

Bayer expects roughly 1,500 construction jobs needed at its New Albany, Ohio, campus for small-molecule drug production requiring specialized process equipment, utilities and waste...

Read source
packaging-gateway.com /4 weeks ago

Bayer launches recyclable mono-PP Talcid blister in Germany

Bayer has launched a polypropylene-only blister pack for Talcid in Germany after bringing the format to Slovenia in late 2025. The post Bayer launches recyclable mono-PP Talcid bli...

Read source
handelsblatt.com /2 weeks ago

USA: „Am schnellsten wachsender Markt“ – Bayer investiert 2,2 Milliarden Dollar in neues US-Werk

In Ohio will der Pharmakonzern künftig Krebs-, Herz- und Nierenmedikamente herstellen. Bayer stärkt damit sein US-Geschäft – mitten in Trumps Kampf gegen hohe Arzneimittelpreise.

Read source
kn-online.de /2 weeks ago

Bayer will über zwei Milliarden Dollar in US-Werk investieren

Bayer plant eine neue Produktionsstätte in Ohio und investiert dafür 2,2 Milliarden Dollar. Was der Konzern sich von dem Standort verspricht.

Read source
thehindubusinessline.com /1 month ago

Bayer to bring 10 products to world market in 10 years

In soy, ‘Vyconic 1’ is expected to be introduced next year in the US and Canada, and ‘Intacta 5+’ is expected to be introduced in the 2027-28 growing season in Brazil

Read source
manufacturingdive.com /2 weeks ago

Bayer to invest $2.2B in Ohio pharmaceutical facility

The drugmaker plans to develop a “flexible, modular campus” with advanced digital and automation technologies. The first phase is set to be ready in 2031.

Read source
insurancejournal.com /1 month ago

Bayer Faces Pivotal Test of $7.25 Billion Roundup Settlement

Bayer’s Monsanto unit heads to a Missouri state court on Monday seeking approval of a $7.25 billion settlement that could resolve tens of thousands of U.S. lawsuits alleging that i...

Read source
law360.com /3 weeks ago

Bayer's COVID Vax IP Suits Against Moderna, Pfizer Survive

Bayer CropScience was cleared to pursue its patent infringement suits against COVID-19 vaccine makers Pfizer, BioNTech and Moderna, after a judge sitting in Delaware upheld its cas...

Read source
handelsblatt.com /1 month ago

Bayer-Anhörung: Monsanto fordert von US-Gericht Genehmigung des „Roundup“-Vergleichs

Ein US-Gericht beschäftigte sich am Montag mit einem möglichen Milliardenvergleich für Bayer. Damit sollen zehntausende Klagen beigelegt werden. Eine Entscheidung steht allerdings...

Read source
pharmexec.com /3 days ago

<![CDATA[Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion ]]>

Read source
thehindubusinessline.com /1 week ago

Bayer expands its direct seeded rice program to over 2 lakh acres in 2026

Through the initiative, Bayer aims to support farmers in navigating the transition to DSR with the right combination of technologies, agronomic expertise and on-ground support

Read source
insurancejournal.com /3 weeks ago

Bayer Faces Trial Test of Remaining Roundup Claims After Supreme Court Win

Attorneys for three cancer patients told a Missouri jury on Sept. 29 that Bayer’s Monsanto unit failed to adequately test its Roundup weedkiller before selling it, starting a trial...

Read source
pharmexec.com /3 weeks ago

<![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>

Read source
pharmexec.com /1 month ago

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Read source
pharmexec.com /3 weeks ago

<![CDATA[Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz ]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

Read source
law360.com /2 days ago

Genentech, Novartis Sue Amneal Over Bid To Sell Xolair Copy

Genentech Inc. and Novartis Pharmaceuticals Corp. have filed a patent infringement suit in Delaware federal court, claiming Kashiv BioSciences' bid to sell a biosimilar copy of the...

Read source
pharmexec.com /1 month ago

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Read source
agwired.com /1 month ago

Deltapine® Launches “Committed to Cotton Communities”

Bayer’s Deltapine® cotton seed brand has announced a new program designed to help strengthen rural communities by encouraging cotton growers to nominate local nonprofit organizatio...

Read source
thehindubusinessline.com /1 week ago

Bayer to distribute, market INERA’s crop nutrition product

Bayer partners with Absolute’s INERA to market climate-resilient crop solution in India, boosting nutrient use efficiency via AI-driven analytics

Read source
law360.com /4 weeks ago

Vividion Investor Wants IP Suit Over $2B Bayer Deal Revived

CHP III LP urged the Delaware Supreme Court on Wednesday to revive its suit over allegedly diverted intellectual property in Vividion Therapeutics Inc.'s $2 billion sale to Bayer C...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV,...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bayer U.s.

supplychain247.com

Recent coverage from public sources
Public source

agwired.com

Recent coverage from public sources
Public source

enr.com

Recent coverage from public sources
Public source

handelsblatt.com

Recent coverage from public sources
Public source

insurancejournal.com

Recent coverage from public sources
Public source

kn-online.de

Recent coverage from public sources
Public source